He Q - Search Results

1

Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.

Wei M, He Q, Yang Z, Wang Z, Zhang Q, Liu B, Gu Q, Su L, Yu Y, Zhu Z, Zhang G. Wei M, et al. Among authors: he q. BMC Cancer. 2014 Jan 8;14:10. doi: 10.1186/1471-2407-14-10. BMC Cancer. 2014. PMID: 24401087 Free PMC article.

2

[Clinical-pathological characteristics and survival of triple negative breast cancer].

He Q, Wang J, Shao YG, Zhou XY, Shao ZM. He Q, et al. Zhonghua Yi Xue Za Zhi. 2009 Feb 3;89(4):243-7. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19552840 Clinical Trial. Chinese.

3

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.

Song LX, Xu L, Li X, Chang CK, Zhang Y, Wu LY, He Q, Zhang QX, Li X. Song LX, et al. Among authors: he q. Ann Hematol. 2012 Dec;91(12):1879-86. doi: 10.1007/s00277-012-1550-y. Epub 2012 Aug 16. Ann Hematol. 2012. PMID: 22895556 Clinical Trial.

4

Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer.

Wang W, Liu L, Wang Z, Wei M, He Q, Ling T, Cao Z, Zhang Y, Wang Q, Shi M. Wang W, et al. Among authors: he q. BMC Surg. 2015 Sep 29;15:106. doi: 10.1186/s12893-015-0094-1. BMC Surg. 2015. PMID: 26420728 Free PMC article.

5

A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.

Wang W, Wang Z, Zhao J, Wei M, Zhu X, He Q, Ling T, Chen X, Cao Z, Zhang Y, Liu L, Shi M. Wang W, et al. Among authors: he q. Oncotarget. 2016 Sep 27;7(39):63526-63536. doi: 10.18632/oncotarget.11362. Oncotarget. 2016. PMID: 27556859 Free PMC article.

6

A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome.

Ji M, Wang L, Shao Y, Cao W, Xu T, Chen S, Wang Z, He Q, Yang K. Ji M, et al. Among authors: he q. Am J Cancer Res. 2018 Jan 1;8(1):165-169. eCollection 2018. Am J Cancer Res. 2018. PMID: 29416929 Free PMC article.

7

Screening of Prognostic Factors in Early-Onset Breast Cancer.

Yu Z, He Q, Xu G. Yu Z, et al. Among authors: he q. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819893670. doi: 10.1177/1533033819893670. Technol Cancer Res Treat. 2020. PMID: 32028860 Free PMC article.

8

Development of a nine-lncRNA signature as a novel prognostic marker of estrogen receptor-negative breast cancer.

Wang Z, Wang J, Liu L, He Q, Wei M. Wang Z, et al. Among authors: he q. Oncol Lett. 2020 Apr;19(4):2979-2988. doi: 10.3892/ol.2020.11391. Epub 2020 Feb 13. Oncol Lett. 2020. PMID: 32218854 Free PMC article.

9

AC016405.3 functions as an oncogenic long non-coding RNA by regulating ERBB3 via sponging miR-22-3p in breast cancer.

Wei M, Wang J, He Q, Liu L, Wang Z. Wei M, et al. Among authors: he q. J Clin Lab Anal. 2021 Sep;35(9):e23952. doi: 10.1002/jcla.23952. Epub 2021 Aug 17. J Clin Lab Anal. 2021. PMID: 34403532 Free PMC article.

10

Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.

Xu F, Yang R, Wu L, He Q, Zhang Z, Zhang Q, Yang Y, Guo J, Chang C, Li X. Xu F, et al. Among authors: he q. Cancer Lett. 2012 Apr 1;317(1):33-40. doi: 10.1016/j.canlet.2011.11.012. Epub 2011 Nov 23. Cancer Lett. 2012. PMID: 22120066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,753 results

Search Page

Filters